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Aspartylglucosaminuria (AGU) is a lysosomal storage
disease caused by a metabolic disorder of lyso-
somes to digest Asn-linked glycoproteins. The
specific enzyme linked to AGU is a lysosomal hydro-
lase called glycosylasparaginase. Crystallographic
studies revealed that a surface loop blocks the cata-
lytic center of the mature hydrolase. Autoproteolysis
is therefore required to remove this P loop and open
up the hydrolase center. Nonetheless, AGU muta-
tions result in misprocessing of their precursors
and are deficient in hydrolyzing glycoasparagines.
To understand the catalytic and structural conse-
quences of AGU mutations, we have characterized
two AGU models, one corresponding to a Finnish
allele and the other found in a Canadian family. We
also report a 2.1 A˚ resolution structure of the latter
AGU model. The current crystallographic study pro-
vides a high-resolution structure of an AGU mutant.
It reveals substantial conformation changes at the
defective autocleavage site of the AGU mutant,
which is trapped as an inactive precursor.
INTRODUCTION
Aspartylglucosaminuria (AGU) is a genetic disease caused by
the failure of lysosomes to process the protein-to-carbohydrate
linkage of asparagine-linked glycoproteins (Aula et al., 2001).
Such a disorder results in the accumulation of glycoasparagines
in the lysosomes of virtually all cell types, with severe clinical
symptoms involving the central nervous system, skeletal abnor-
malities, and connective tissue lesions. AGU has been reported
worldwide, with close to 30 different alleles being characterized
so far (Hreidarsson et al., 1983; Mononen et al., 1993; Opladen
et al., 2014; Saarela et al., 2004). Because of a founder effect,
AGU is enriched in Finland. However, the majority of AGU alleles
are found outside of Finland, with sporadic AGU causing muta-
tions (Aronson, 1999; Hreidarsson et al., 1983; Ikonen et al.,
1991; Opladen et al., 2014).
AGU mutations occur in the gene of a well known lysosomal
enzyme, glycosylasparaginase (GA), which is also known as
aspartylglucosaminidase (Aronson, 1999; Mononen et al.,
1993). GA is an amidase that cleaves the asparagine-linkedStructure 22, 1855–18glycoprotein. Like all other members of the N-terminal nucleo-
phile hydrolase family, GA is synthesized as an enzymatically
inactive precursor (Brannigan et al., 1995). An obligatory pro-
cessing step for activating GA is, therefore, an intramolecular
or cis-autoproteolysis used to cleave the single-chain polypep-
tide precursor into the heavy (a) and light (b) subunits and to
expose the critical nucleophile of the amidase at the newly
generated N terminus of the b subunit. This type of site-specific
autoproteolysis of the polypeptide precursor is also required to
activate many other critical enzymes (Dembek et al., 2012; Pau-
lus, 2000). Molecular characterizations of AGU causing muta-
tions revealed problems in the autoproteolytic processing of
their precursors. Therefore, AGU molecules are misprocessed
and are retained at the preautoproteolysis stage as single-chain
precursors, inactive for glycoprotein processing (Aronson, 1999;
Saarela et al., 2001).
To understand the molecular details of the disease, a detailed
characterization of AGU causing mutations is essential. In addi-
tion, high-resolution crystallographic analyses of AGUmolecules
are critical for a precise understanding of the structural conse-
quences of AGUmutations. However, amajor obstacle for struc-
tural and biochemical studies of AGU is the difficulty to obtain
purified and active human GA in sufficient quantity (Heiskanen
et al., 1994). Because of failed attempts to overexpress active re-
combinant humanGA, the proteinmaterial used to determine the
only available structure of human GA, in its autoproteolyzed
form, was purified from human blood leukocytes (Oinonen
et al., 1995; Tikkanen et al., 1996b). Furthermore, efforts for
over more than a decade to crystallize diffraction-quality crystals
of the humanGA precursor using a variety of expression systems
have been unsuccessful (Saarela, 2004). To the contrary, both
the precursor and autoproteolyzed forms of Flavobacterium
GA have been purified at sufficiently high quantity and quality
for structural, biochemical, and biophysical studies (Guo et al.,
1998; Xu et al., 1999).
All data indicate that, from bacteria to eukaryotes, GAs are
conserved in primary sequences and tertiary structures and
utilize the same cis-autoproteolysis mechanism to activate their
hydrolase activities. Molecular and biochemical studies have
revealed a mechanistic relationship between human and bacte-
rial GAs. Both utilize the same mechanism for autoactivation
through intramolecular autoproteolysis (Saarela, 2004; Xu
et al., 1999). They also share the same hydrolysis mechanism
for processing glycoasparagines (Liu et al., 1998; Tikkanen
et al., 1996a). It has also been shown that the glycosylation of
GA that occurs in mammalian cells is not absolutely required
for either the autoproteolysis or hydrolase activity (Tikkanen61, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1855
Figure 1. Autoproteolysis and Hydrolysis Activities of AGU Mutants
(A) Autoproteolysis analysis of the G172D mutant. Autoproteolysis of purified
G172D precursor protein was initiated by incubating the precursor at 37C in a
solution of 20 mM Tris (pH 7.4), 50 mM NaCl, and 1 mM EDTA. Aliquots were
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1856 Structure 22, 1855–1861, December 2, 2014 ª2014 Elsevier Ltdet al., 1995). Deletion of theN-glycan in one of the subunits could
be tolerated. The bacterial and human GAs share highly signifi-
cant sequence homology, with an overall 36% identity and addi-
tional 53% conserved similarity. Furthermore, structural studies
have provided direct evidence that these two enzymes share a
conserved abba structure (Oinonen and Rouvinen, 2000). More
importantly, they have essentially identical autoproteolytic cen-
ters (Guo et al., 1998; Oinonen et al., 1995), with 100% identical
residues forming the autocatalytic site and a root-mean-square
deviation (rmsd) of 0.6 A˚ for all of these conserved active site res-
idues. Together, these data confirm the suitability of the bacterial
enzyme as a model to analyze the consequences of mutations in
AGU patients at the atomic level.
In this study, we carried out biochemical analyses of two
model mutants with AGU alleles. Autoproteolysis activities of
these mutant proteins are diminished dramatically, with a half-
life (t1/2) ranging from hours to days, in contrast to being a spon-
taneous process (<1 min) for the wild-type GA. Furthermore, we
determined a crystallographic structure of one AGU mutation
found in a Canadian family (Coulter-Mackie, 1999). The crystal-
lographic snapshot at a resolution of 2.1 A˚ has provided a struc-
tural basis of the AGU disease caused by a missense mutation.
RESULTS AND DISCUSSION
Construction and Biochemical Characterization of AGU
Mutants
To study the functional and structural consequence of AGU
missense mutations while overcoming the difficulty of express-
ing human GA, we resorted to a model enzyme. As discussed
above, Flavobacterium GA appears to be an excellent model to
study the structural consequences of AGU mutations. In this
study, we generated two AGU model enzymes. One is a Finnish
allele that carries amutation of a nucleotide C to T and, therefore,
changes residue 234 of human GA from a threonine to an isoleu-
cine (Saarela et al., 2001). The other mutant is a Canadian allele
that carries a missense mutation with a change of a nucleotide
from G to A and, therefore, changes the residue 203 of human
GA from a glycine to an aspartic acid (Coulter-Mackie, 1999).
Based on structural and homology alignments (Guo et al.,
1998), Gly172 and Thr203 of Flavobacterium GA is equivalent
to the Gly203 and Thr234 of the human counterpart, respec-
tively. We have therefore generated two Flavobacterium model
mutants. One carries a Gly-to-Asp missense mutation at bacte-
rial residue 172 (called G172Dmutant), and another has a Thr-to-
Ile missense mutation at bacterial residue 203 (called T203I
mutant). Precursor proteins of these mutants have been purified
to homogeneity. As shown in Figure 1, the wild-type GA auto-
cleaves spontaneously and, therefore, is purified entirely as athen removed at various time points, as indicated, and analyzed by SDS-
PAGE. The precursor (a-b), autocleaved subunits (a and b), and wild- type GA
(WT) are marked. Lane M is a mixture of molecular weight markers.
(B) Autoproteolysis analysis of the T203I mutant. Purified T203I precursor
protein was analyzed as in (A).
(C) Enzyme hydrolysis assays. Purified AGU mutant or wild-type GA proteins
were incubated at 37C for 0–7 days to measure their hydrolase activities. See
Experimental Procedures for detailed assay conditions. The activity of wild-
type GA is normalized to 100%. Data are averages of three repeats ± SD.
All rights reserved
Table 1. Crystallographic Data Collection and Refinement
Statistics
G172D Crystal
Resolution (A˚)a 48.1—2.1 (2.16–2.10)
Space group P1
Cell dimensions
a, b, c (A˚) 45.8, 50.6, 61.2
a, b, g () 86.3, 91.0, 107.8
No. of molecules per asymmetric unit 2
I/s-I 14.2 (9.5)
Completeness (%) 90.0 (90.3)
No. of reflections 103,797 (8,672)
Unique reflections 27,448 (2,257)
Rsym (%)
b 5.2 (9.8)
Structure Refinement
Rwork
c 0.1920
Rfree
d 0.2568
Rmsdse
Bond lengths (A˚) 0.0165
Bond-angles () 1.7604
Ramachandran plot
Most favored regions (%) 96.7
Additional allowed regions (%) 3.3
Average B factors (A˚2)
Main chain 18.6
Side chain 21.5
Water 24.3
aNumbers in parenthesis refer to the outermost resolution bin.
bRsym = ShSijIhi-Ihj / ShSiIhi for the intensity (I) of i observation of
reflection h.
cRwork = SjFobs – Fcalcj/SjFobsj, where Fobs and Fcalc are the observed and
calculated structure factor amplitudes, respectively.
dRfree was calculated as Rwork but with 5% of the amplitudes chosen
randomly and omitted from the start of refinement.
eRmsds are deviations from ideal geometry.
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Aspartylglucosaminuria Mutant Structuremature form with a and b subunits. In contrast, both AGUmutant
proteins are defective to some degree in autoproteolysis. The
G172D mutant was purified as a single-chain precursor and
remains as a precursor even after 16 hr of incubation at 37C
(Figure 1A), whereas the T203I mutant can be purified as
a single-chain precursor, but about half of the precursor
form undergoes autocleavage within 8 hr of incubation at 37C
(Figure 1B).
To ask whether the mature form of the AGU mutants gener-
ated by the in vitro autoprocessing is an active hydrolase, we
performed a time course experiment and analyzed the level of
hydrolase activity. Wild-type and mutant proteins were incu-
bated at 37C to initiate autoproteolysis, and samples were
taken at various time points to measure the activity of hydrolyz-
ing a glycoasparagine (Figure 1C). As expected from the gel
analysis of autoproteolysis (Figure 1A), the G172Dmutant essen-
tially has no hydrolase activity throughout the in vitro autoactiva-
tion. On the other hand, the T203I mutant protein showed a small
but significant level of hydrolase activity, 7% of the wild-typeStructure 22, 1855–18activity at the initial time point. This detectable hydrolase activity
further increased to about 10% of the wild-type level after 1 day
of in vitro autoprocessing, correlating well with a concurrent
increase of the autocleaved form (Figure 1B). This increase in
activity is even more significant when considering that the
wild-type enzyme actually showed a continuous drop of hydro-
lase activity over time, likely because of enzyme denaturation
during the thermal incubation. It is possible that the T203I mutant
enzyme is more thermally stable than the wild-type enzyme, and
its hydrolase activity was further elevated by the thermal incuba-
tion. Nonetheless, a more likely explanation for the increase of
hydrolysis activity of the T203I mutant protein is that more active
hydrolase was being generated through autocleavage during the
in vitro thermal incubation. Therefore, even though the T203I
mature enzyme is not as efficient as the wild-type enzyme, it still
has some hydrolase activity to process glycoasparagines. These
data suggest that an in vitro activation of autoproteolysis can be
applied to enhance the hydrolase activity of the AGUmutant. It is
worth noting that an enhancement of autoprocessing to just
partially restore GA hydrolase activity in lysosomes might be
beneficial for AGU patients.
Crystal Preparation to Capture AGU Mutants at the
Preautoproteolysis Stage
To determine the preautoproteolysis structure, the AGU precur-
sor would need to be stabilized up to several days for crystal
growth. However, we found that both the purified G172D and
T203I mutant precursors undergo autoproteolysis to the mature
forms during the several days required for crystallization. Glycine
has been used as a reversible inhibitor of autoproteolysis to
stabilize precursors of active GA proteins for crystallization
(Wang and Guo, 2010; Xu et al., 1999). To find an analogous in-
hibitor for the AGU-causing variants, we screened a library of
glycine-like small molecules, which led to the identification that
L-aspartic acid b-hydroxamate (b-AHA) was able to stabilize
the G172D precursor for up to several days for crystallization.
In the presence of b-AHA, crystals containing the G172D precur-
sor were obtained for structure determination. However, proteol-
ysis could be resumed by removing b-AHA from the G172D
samples through dialysis. On the other hand, despite vigorous
efforts, no effective inhibitor has been found to be able to stabi-
lize the precursors of the T203I mutant for crystallization.
The Structures of the Precursor and the Mature Form
Were Found in a Single Crystal
Structures of the G172D mutant have been determined by X-ray
crystallography and refined to 2.1 A˚ resolution. Crystallographic
statistics are summarized in Table 1. The crystal has a triclinic
unit cell and contains two molecules in the asymmetric unit.
These two molecules form a bimolecular assembly through the
same interfaces as observed previously in the structures of
precursor homodimers (Xu et al., 1999) or the equivalent a2b2
heterotetramers of autocleaved enzymes (Guo et al., 1998; Oino-
nen et al., 1995). However, unique to this G172D crystal form,
one molecule was in its precursor form with a bound b-AHA,
and the other molecule was in the mature/autocleaved form
(with a and b subunits) and without any sign of b-AHA binding.
The space group and cell constants of the G172D crystal
(P1, a = 45.8, b = 50.6, and c = 61.2 A˚; a = 86.3, b = 91.0, and61, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1857
Figure 2. Overall Structure of the G172D Precursor in Complex with
b-AHA
Shown is a ribbon representation of the G172D precursor structure, with the
bound b-AHA molecule shown as a stick model. The arrow points to the
defective scissile peptide bond between Asp151 and Thr152 in the P loop.
The b-AHA molecule and side chain of the autoproteolysis key residue Thr152
are shown by atom type: yellow for carbon atoms, blue for nitrogen atoms, and
red for oxygen atoms. The side chains of the two separate AGU mutations
studied, Asp172 and Ile203, are shown in green.
Structure
Aspartylglucosaminuria Mutant Structureg = 107.8) are closely related to those of the precursor crystals
(P1, a = 46.3, b = 52.8, and c = 62.4 A˚; a = 80.8, b = 90.5, and g =
105.1), whereas crystals of autocleaved enzymes were typically
grown in a monoclinic space group (P21, a = 46.2, b = 97.3, and
c = 61.8 A˚; b = 90.3) (Cui et al., 1999). Therefore, it is possible
that the G172D crystal was initially grown with precursor homo-
dimers and that one of the two precursors was able to auto-
cleave in the crystal. It has been well documented that GA
crystals retain both the autoproteolysis and hydrolysis activities
(Oinonen et al., 1995; Wang and Guo, 2007, 2010). The differ-
ence in autocleavage of the two molecules in the G172D crystal
appears to be due to differences in crystal contacts of a surface
loop near the active site that, in turn, alter binding affinity and
precursor stabilization by b-AHA (see below). Therefore, in this
report, we are studying both the structures of the precursor
and the mature form of the G172D mutant.
Structural Comparisons between the G172D Precursor
and Its Autocleaved Form
The overall structure of the G172D precursor in complex with
b-AHA is shown in Figure 2. The G172D precursor folds into an
abba sandwich, with a surface loop (denoted precursor P loop,
containing residues 139–151) located next to the autocleavage
site. When the G172D precursor is compared with its mature
counterpart, a small but significant difference in conformation
is found at the surface loop containing the mutated residue
Asp172, where the main chain of the loop has shifted by more
than 3 A˚ (Figure S1 available online). As a result, the mature
G172D enzyme has adopted a wider opening near the substrate1858 Structure 22, 1855–1861, December 2, 2014 ª2014 Elsevier Ltdsite. There are two additional disordered surface loops in the
mature form structure, and both are located outside of the cata-
lytic center. Excluding these disordered loops, the precursor
structure of the G172D mutant is very similar to its autocleaved
form. The rmsd between the two structures is 0.83 A˚ for all
main-chain atoms of common residues (residues 3–44, 56–
138, 152–170, and 174–295). The slightly high rmsd is due to
small differences in loops and small movements of flanking heli-
ces (containing residues 31–45 and residues 126–136, shifted by
about 1.8 A˚). However, these small conformational shifts appear
to be related to loop disorder, possibly as a result of differences
in crystal contacts. There were no other major conformational
differences observed between the G172D precursor and its
autocleaved structure.
Structural Comparisons with GA Wild-Type Enzyme and
Active Precursors
Comparedwith a GAwild-type structure reported previously, the
G172Dmature enzyme has an essentially identical structure (see
Supplemental Results). Likewise, no gross conformational differ-
enceswere observedwhen the structure of theG172D precursor
was compared with GA active precursors published previously
(Protein Data Bank [PDB] ID code 9GAC) (Xu et al., 1999). The
rmsd between these two precursor structures is 0.82 A˚ for all
main-chain atoms of the common 284 residues (including sur-
face loops). However, some localized conformational changes
are found as a result of the single residue change at residue
172. In the active precursor structure, residues 46–51 are in an
unstructured loop. However, in the G172D precursor, these
same residues join residues 31–45 (denoted previously as aH2
helix in Guo et al., 1998) to form a continuous a helix with one
additional turn (Figure 3). Interestingly, no electron density was
observed for these same residues in the mature G172D struc-
ture, suggesting dynamic flexibility or static disorder in this re-
gion of the mutant. The extended a helix in the G172D precursor
structure appears to be stabilized by a new salt bridge between
the side chain of Asp172 and the side chain of Arg56 as well as
the binding of b-AHA. Furthermore, near the autocleavage site,
there are also dramatic conformational changes. As shown in
Figure 3, the bulky side chain of Asp172 in the mutant precursor
pushes the P loop and the defective scissile bond to take a
different conformation. As a result of these conformational
changes, the side chains of Ser50 in these two structures are
pointing in almost opposite directions, with side-chain atom
Og being displaced by as much as 11.1 A˚ (Figure 3). Similarly,
the side-chain hydroxyl oxygen of Tyr53 also moves by as
much as 14.3 A˚ and is pointed toward opposite sides of the helix.
These conformational changes result in a more relaxed back-
bone at the defective scissile bond (see details below).
Comparing b-AHA Binding with Glycine Binding
The binding site of b-AHA to the G172D precursor is located near
the autocleavage site at the same cavity as observed previously
for the glycine inhibitor bound to an active GA precursor (Xu
et al., 1999). The electron density map around the scissile pep-
tide bond of the G172D mutant in complex with b-AHA is shown
in Figure 4A. This cavity is a partial substrate site and forms
around the conserved residues Arg180, Asp183, and Gly204
that directly interact with the aspartate moiety of the GAAll rights reserved
Figure 3. Structural Comparison of the Au-
tocleavage Sites in the G172D Mutant and
an Active GA Precursor
Shown is a stereo view of the superimposition of
the autocatalytic site residues in the G172D pre-
cursor (green) and an active GA precursor model
published previously (orange; Xu et al., 1999), with
black labels for well superimposed residues. Side-
chain atoms of GA are shown as stick models, and
main-chain traces of the P loop flanking the scis-
sile bond, residues 149–152, are shown as tubes.
Also shown are bound inhibitors (a b-AHA or a
glycine). Note the mutation of the side chain at
residue 172 from a glycine (an orange sphere for
Ca) to an aspartic acid (green side chain). Resi-
dues 46–51 are in an unstructured loop in the
active GA precursor (orange tube) but fold into an
a helix (green ribbon) in the G172D mutant.
Structure
Aspartylglucosaminuria Mutant Structuresubstrates in the mature/autocleaved enzyme (Guo et al., 1998;
Oinonen et al., 1995). In the precursor of active GA, this cavity is
only accessible to small molecules such as glycine through a
narrow port. However, as noted above, the G172D precursor
adopts a wider opening for this cavity because of a conforma-
tional shift of a surface loop containing the mutated side chain
of Asp172. This would explain how the G172D precursor could
bind the larger molecule b-AHA. The binding modes of both in-
hibitors to the small cavities are similar. They utilize their
a-carboxylate ends to form salt bridges with the conserved res-
idue Arg180 (Figure 4B). At the same time, their a-amino groups
interact with the conserved residues Asp183 and Gly204 via
hydrogen bonds. These conserved interactions are similar to
those observed in the enzyme/substrate or enzyme/product
complexes (Oinonen et al., 1995; Wang and Guo, 2007).
The Autoproteolytic Center of the G172D Precursor
Near the scissile peptide bond (Asp151-Thr152), the G172D
mutant precursor exhibits substantial conformational differ-
ences when compared with that of an active GA precursor
(Figure 3) (Wang and Guo, 2010; Xu et al., 1999). As shown in
Figure 3, mutation at residue 172, from a glycine to an aspartic
acid, alters the main-chain trace near the scissile peptide bond
by about 3.4 A˚. Furthermore, packing of side chains also
changed dramatically so that the side chains of Asp151 pointed
roughly in opposite directions, with Od1 shifts by as much as
8.4 A˚. This conformational change breaks a key interaction be-
tween the side chains of residues Asp151 and Thr152, which
has been demonstrated to be critical in holding the conforma-
tional strains important for driving autoproteolysis (Qian et al.,
2003), through a ‘‘twist-and-break’’ mechanism (Wang and
Guo, 2010; Xu et al., 1999). As a result, the structural constraints
observed in an active GA precursor are no longer present in the
G172D precursor. Therefore, a backbone relaxation near the
defective scissile peptide bond appears to be the cause of trap-
ping AGU molecules at the nonproductive precursor stage.
A Low Level of cis-Autoprocessing Activity of the AGU
Mutant
Both AGU mutants have a low activity of autoproteolysis to
generate an active hydrolase. This is demonstrated by an activity
of about 4%–10% of wild-type activity in the hydrolase assayStructure 22, 1855–18after 2–7 days of incubation at 37C (Figure 1C). During the pro-
cess of crystallization, which took 5–10 days at 4C, one of the
twomolecules of the G172Dmutant in the P1 unit cell underwent
autoproteolysis. Differences in crystal contacts appear to play a
role in the effectiveness of b-AHA inhibition. Apparently, for the
residual autoproteolysis to occur, the P loop near the auto-
cleavage site of AGU mutants would have to change from the
defective conformation (green trace in Figure 3) to an active
conformation, presumably similar to the twisted conformation
observed in an active precursor (orange trace in Figure 3). Inter-
estingly, for the precursor structures determined so far (Qian
et al., 2003; Wang and Guo, 2010; Xu et al., 1999), the P loop re-
gions all have a significantly higher B factor or even lack electron
density for part of the loop, indicating dynamic or static disorder
of this region. Therefore, it is plausible that a thermal motion or
flexibility of the P loop would result in a small fraction of the
AGU precursors to adopt an active conformation for autopro-
teolysis. Nonetheless, such an active conformation would have
steric conflicts with the bound b-AHA molecules (Figure 3).
This would explain why no density of b-AHA was found in the
active site for the autocleaved molecule in the crystal.
Conclusions
Here we report mutational and biochemical studies on two AGU
mutant models. We also present a high-resolution structure of an
AGU model to study the structural consequences of a disease-
causing mutation. Neither of these two missense mutations of
AGU molecules is located close enough to the catalytic center
for a direct involvement in catalysis (Figure 2). Therefore, a loss
of a functional group directly required for autoproteolysis is not
the cause of AGU deficiency. Instead, as demonstrated by the
structure of the G172Dmutant, it is the indirect effects of themu-
tation on the conformation that propagate to the defective scis-
sile peptide bond. As shown in Figure 3, mutation at residue 172
has altered the backbone trace flanking the scissile peptide
bond at residues 151–152 as well side-chain packing and sec-
ondary structure. These localized conformational changes, in
turn, result in an unproductive precursor trapped at the preauto-
proteolysis stage that is incapable of accommodating and pro-
cessing glycoasparagines. Nonetheless, small molecules have
been shown to be able to stimulate autoprocessing of GA mu-
tants with an autoproteolysis defect similar to AGU molecules61, December 2, 2014 ª2014 Elsevier Ltd All rights reserved 1859
Figure 4. The Structure of b-AHA as Bound
to the G172D Precursor
(A) The cyan electron density corresponds to a
2Fo Fc type map at 2.1 A˚ resolution contoured at
the 1.2-s level. The defective scissile peptide
bond is located between Asp151 and Thr152.
Bound b-AHA and side chains of a few key active
site residues are shown by atom type: yellow for
carbon atoms, blue for nitrogen atoms, and red for
oxygen atoms. A bound waster molecule is shown
as a red sphere.
(B) Hydrogen bond network at the autocleavage
site with the bound b-AHA inhibitor. Active site
residues of the G172D precursor are shown as
stick model, whereas the b-AHA inhibitor is shown
as a ball and stick model. Dashed lines indicate
the hydrogen bond interactions with distances in
angstroms.
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Aspartylglucosaminuria Mutant Structure(Guan et al., 1998). As shown in Figure 1C, in vitro autoprocess-
ing of AGUmutants could increase the activity of hydrolyzing gly-
coasparagines. Therefore, in principle, the misprocessed AGU
precursors represent excellent targets for designing small mole-
cules to ameliorate the AGU disorder. There have been success-
ful precedents of identifying small molecules to reduce protein
misfolding, to stabilize the native state, and/or to activate
trans-proteolytic processing of proenzymes (Petrassi et al.,
2005; Ray et al., 2005; Wolan et al., 2009). The AGU precursor
structure reported here provides a solid foundation for the struc-
ture-based design of small molecules to rescue AGUmutants by
activating cis-autoproteolysis in the hope to further develop
them into therapeutics to alleviate the suffering of AGU patients.
EXPERIMENTAL PROCEDURES
Hydrolase Activity Assay
Hydrolase activity was assayed by a method modified from an approach
described previously (Liu et al., 1998). Details are provided in the Supplemental
Results.
Protein Purification and Crystallization
Wild-type GA and AGU mutant proteins were overexpressed and purified
using protocols published previously (Cui et al., 1999). Crystals of the
G172D mutant in complex with b-AHA were obtained under crystallization
conditions of 0.2 M NaCl, 0.1 M Bis-Tris (pH 6.5), 25% polyethylene glycol
3350, and a protein concentration of 2 mg/ml.
Data Collection and Processing
Before flash-cooling in liquid nitrogen for data collection, crystals were soaked
in a reservoir solution supplemented with 20% glycerol. X-ray data were
collected at 100 K using the beamline X29 at the National Synchrotron Light
Source, Brookhaven National Laboratory. The data were processed with the
HKL2000 (Otwinowski and Minor, 1997) and the CCP4 suite (Collaborative
Computational Project, Number 4, 1994). The crystal has P1 symmetry with
two protein molecules in the asymmetric unit.
Structure Determination and Refinement
The structures of the G172D mutant were determined by the molecular
replacement method using the previously published structure of the D151N
mutant (PDB ID code 1P4K) (Qian et al., 2003). To avoid model bias, the initial
MR phases were calculated by omitting the P loop residues 148–158, which1860 Structure 22, 1855–1861, December 2, 2014 ª2014 Elsevier Ltdinclude the scissile peptide bond at residues 151–152. Molecular replacement
was performed withMolrep, and refinements were carried out with the Refmac
program, with 5% of the total reflection data excluded from the refinement
cycles and used to calculate the free R factor (Rfree). This partial model was
further subjected to rigid body and restrained refinements, with model
rebuilding done with COOT (Emsley and Cowtan, 2004) to obtain the final
structure. X-ray data collection, processing, and structure refinement statistics
are summarized in Table 1. Figures were made with the program PyMOL
(Delano Scientific).
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